An Optometrist’s Guide to Color Vision Testing: Common Tests, How to Perform Them, and Clinical Interpretation with cheat sheets
Introduction: Why Color Vision Testing Matters in Optometry
Color vision testing is an important part of a comprehensive eye examination, particularly when evaluating children, patients with suspected optic nerve disease, unexplained visual changes, or individuals pursuing occupations that require accurate color discrimination.
Although color vision deficiency is commonly referred to as color blindness, most affected individuals can still perceive colors. Their difficulty lies in distinguishing particular hues.
For optometrists, the key is understanding not only whether a patient has a color vision deficiency, but also whether it is congenital or acquired, which color pathways are affected, and whether further investigation is necessary.
1. Understanding the Three Types of Color Vision Deficiency
Normal human color vision depends primarily on three types of retinal cones:
L-cones: Most sensitive to longer wavelengths.
M-cones: Most sensitive to medium wavelengths.
S-cones: Most sensitive to shorter wavelengths.
Differences in the function or distribution of these cones can produce characteristic color vision deficiencies.
Type | Primary defect | Clinical characteristics |
Protanopia | Absent functional L-cone mechanism | Red-green confusion and reduced sensitivity to long-wavelength red light |
Protanomaly | Altered L-cone sensitivity | Variable red-green discrimination difficulty |
Deuteranopia | Absent functional M-cone mechanism | Red-green confusion |
Deuteranomaly | Altered M-cone sensitivity | Most common inherited color vision deficiency |
Tritanopia | Absent functional S-cone mechanism | Blue-yellow confusion |
Tritanomaly | Altered S-cone sensitivity | Reduced blue-yellow discrimination |
Achromatopsia | Severe or absent cone function | Markedly reduced color perception, often with photophobia, nystagmus, and reduced visual acuity |
Inherited red-green deficiencies are X-linked and more common in males. Blue-yellow disturbances may occur with inherited conditions but are particularly relevant when investigating acquired ocular disease.
Clinical pearl: Acquired color vision defects may be asymmetric, progressive, or associated with reduced visual acuity, visual field abnormalities, and other signs of retinal or optic nerve disease.
2. Ishihara Color Vision Test
The Ishihara color vision test is one of the most widely used screening tools for congenital red-green color vision deficiency.
It consists of pseudoisochromatic plates containing colored dots of different sizes, arranged to form numbers or pathways.
Best for: Rapid screening of inherited red-green deficiencies.
How to perform the Ishihara test
Use the original, well-maintained test booklet under the manufacturer-recommended daylight-equivalent illumination.
Position the plates approximately 75 cm (30 inches) from the patient, or at the distance specified by the booklet.
Hold the plates approximately perpendicular to the patient's line of sight.
Test each eye separately when performing a clinical evaluation, using the patient's appropriate near correction.
Ask the patient to identify the number or pattern on each plate.
Allow approximately 3 seconds per plate for commonly used Ishihara editions, following the specific manual.
Record the responses and score them using the edition-specific answer key.
How to interpret results
Normal color vision: The patient correctly identifies the required number of screening plates.
Red-green deficiency: The patient misidentifies or cannot identify characteristic figures.
Protan versus deutan: Certain editions contain classification plates that help distinguish these defects.
The precise number of permissible errors depends on the booklet edition and screening protocol.
Limitations
Ishihara plates are excellent for red-green screening but do not reliably detect blue-yellow deficiencies. They are also insufficient on their own to quantify severity or evaluate all acquired color vision disorders.
Clinical pearl: A patient with suspected optic neuropathy can have normal Ishihara results. Normal screening does not exclude acquired dyschromatopsia.
3. Hardy-Rand-Rittler (HRR) Color Vision Test
The Hardy-Rand-Rittler (HRR) test is especially valuable because it can assess both red-green and blue-yellow color discrimination.
Unlike Ishihara, HRR typically uses geometric shapes such as circles, triangles, and crosses rather than numbers.
Best for: Screening and classifying red-green and blue-yellow deficiencies, including suspected acquired defects.
How to perform the HRR test
Position the patient under standardized illumination recommended for the test.
Hold the test booklet at approximately 75 cm, following the edition-specific instructions.
Test each eye separately when evaluating ocular disease.
Begin with the demonstration and screening plates.
Ask the patient to identify the shapes and, when required, their locations.
Continue to the diagnostic and severity plates when indicated.
Record the responses and use the manufacturer's scoring criteria.
How to interpret results
HRR can help identify:
Protan defects
Deutan defects
Tritan defects
Approximate severity categories, depending on the edition
Because the test evaluates additional color pathways, it can be particularly helpful in the setting of suspected retinal or optic nerve dysfunction.
Clinical application
Consider a patient with unexplained visual complaints and normal Ishihara results. HRR testing may reveal a blue-yellow color discrimination abnormality that warrants further evaluation.
Clinical pearl: HRR is often a more versatile initial color vision test than Ishihara when acquired color vision loss is a concern, although no plate test independently establishes the underlying diagnosis.
4. Farnsworth Panel D-15 Test
The Farnsworth D-15 test is a color arrangement examination designed to identify clinically significant color confusion patterns.
Rather than recognizing numbers, the patient arranges colored caps into a logical sequence based on hue similarity.
Best for: Evaluating moderate or more pronounced color discrimination defects and characterizing color confusion axes.
How to perform the Farnsworth D-15
Place the D-15 test tray under standardized daylight-equivalent illumination.
Explain that the patient will arrange colored caps by similarity of color.
The first reference cap remains fixed.
Randomize the remaining 15 movable caps.
Ask the patient to select the cap most similar to the fixed reference cap.
Have the patient continue choosing the next closest color until all 15 caps are arranged.
Allow the patient to review and adjust the arrangement before completing the test.
Record the numbered sequence from the underside of the caps and plot it on the D-15 scoring diagram.
Test monocularly when evaluating acquired dysfunction.
How to interpret the D-15
The examiner plots the cap sequence on a circular scoring diagram.
Normal or pass pattern: Connections generally progress around the hue circle without major crossings.
Protan pattern: Confusion lines may align with a protan axis.
Deutan pattern: Confusion lines may align with a deutan axis.
Tritan pattern: Confusion lines may align with a tritan axis.
A few adjacent cap reversals do not necessarily indicate a clinically significant deficiency.
Limitations
A patient with a mild color vision deficiency may pass the standard D-15. For subtle acquired defects, a more sensitive test may be necessary.
Clinical pearl: The D-15 provides additional characterization of color confusion but should not be considered an absolute pass-or-fail measure for all color vision abnormalities.
5. Lanthony Desaturated D-15 Test
The Lanthony Desaturated D-15 uses a similar arrangement principle to the standard Farnsworth D-15, but the colors are less saturated.
The reduced saturation makes it harder to distinguish adjacent caps, increasing sensitivity to certain subtle color discrimination abnormalities.
Best for: Investigating mild acquired dyschromatopsia.
How to perform the Lanthony D-15
Use calibrated, standardized illumination.
Position the desaturated caps randomly with the reference cap fixed.
Test each eye separately.
Ask the patient to arrange the caps in order of closest color similarity.
Record the completed sequence and plot the results using the correct scoring template.
Compare results between eyes and with previous examinations.
Clinical applications
This test may be useful when evaluating patients with suspected:
Optic nerve disorders
Glaucoma-related visual dysfunction
Macular disease
Medication-associated retinal or optic nerve toxicity
Clinical pearl: A patient can pass the standard D-15 yet demonstrate abnormalities on the desaturated version. These findings must still be interpreted alongside visual acuity, media clarity, and the ocular examination.
6. Farnsworth-Munsell 100-Hue Test
The Farnsworth-Munsell 100-Hue Test is a detailed color discrimination test used to quantify hue discrimination and identify patterns of color confusion.
Despite its name, the test contains 85 movable colored caps distributed among four trays.
Best for: Detailed color discrimination assessment, monitoring changes, and selected occupational evaluations.
How to perform the FM 100-Hue test
Prepare all four trays under standardized daylight-equivalent illumination.
Test the patient monocularly when investigating ocular disease.
Randomize the movable caps in the first tray, leaving the two reference colors fixed.
Ask the patient to arrange the caps into a gradual progression of color between the two reference caps.
Repeat the process for each of the four trays.
Record the cap sequences and score them using the official scoring method or software.
Calculate the Total Error Score (TES) and evaluate the color confusion pattern.
Interpretation
The test produces an error score reflecting how accurately the patient arranged the colors.
Lower error scores: Better hue discrimination.
Higher error scores: Poorer hue discrimination.
Characteristic patterns: May suggest specific axes of color confusion.
Results should be interpreted against appropriate age-related normative values, as color discrimination can decline with age.
Unlike simple screening plates, the FM 100-Hue provides a more detailed quantitative assessment.
7. Red Desaturation Test
The red desaturation test is a quick, inexpensive clinical screening technique used during evaluation of suspected optic nerve dysfunction.
It is particularly useful when comparing color perception between the two eyes.
Best for: Bedside assessment of asymmetric color perception in suspected optic neuropathy.
How to perform the red desaturation test
Use a bright red object, such as a red bottle cap or standardized red target.
Position it against a neutral background under consistent lighting.
Ask the patient to look at the red target with the right eye while covering the left.
Repeat with the left eye while covering the right.
Ask: "Does the red look equally bright and vivid in both eyes?"
If there is a difference, ask the patient to describe it or estimate the relative saturation.
For example, a patient may report that red appears vivid in the right eye but washed out or pinkish in the left eye.
Interpretation
Reduced perceived redness in one eye can be associated with optic nerve dysfunction, including optic neuritis.
However, this subjective test is not specific for optic neuropathy. Retinal disease, media opacity, differences in illumination, and other factors may influence the result.
Clinical pearl: Red desaturation should be interpreted alongside visual acuity, RAPD testing, visual fields, contrast sensitivity, OCT, and the clinical examination. It is not a replacement for formal color vision testing.
8. Anomaloscope Testing
The anomaloscope is a specialized instrument used to characterize congenital red-green color vision abnormalities.
It is regarded as a reference-standard technique for classifying red-green color vision deficiencies.
Best for: Detailed confirmation and classification of congenital protan and deutan abnormalities.
How to perform anomaloscope testing
Seat the patient at the anomaloscope and provide the required adaptation period.
Have the patient view the split visual field through the eyepiece.
One half presents a mixture of red and green light; the other presents a yellow comparison field.
Ask the patient to adjust the red-green mixture until its color matches the yellow field.
Adjust the yellow field luminance as required by the instrument protocol.
Obtain the patient's acceptable matching range through repeated trials.
Interpret the matching midpoint and range using the instrument's reference criteria.
Interpretation
A typical trichromat accepts a relatively narrow range of red-green mixtures. Individuals with anomalous trichromacy may require a shifted mixture, while dichromats generally accept a broader range under appropriate testing conditions.
Anomaloscopes are not commonly available in routine primary eye care practices, but they may be used in specialized clinics, research centers, and occupational assessments.
9. Computerized Color Vision Testing
Computerized color vision testing provides another option for assessing color discrimination.
Examples include the Cambridge Colour Test, Cone Contrast Test, Colour Assessment and Diagnosis (CAD) test, and approved computerized occupational screening systems.
These tests may quantify color discrimination thresholds or individual cone-mediated performance.
General testing procedure
Confirm that the software and display meet the manufacturer's calibration requirements.
Control room illumination and viewing distance.
Provide the appropriate refractive correction.
Explain the task and complete the training demonstration.
Have the patient identify targets, indicate their orientation, or complete color matching tasks.
Record the software-generated scores and compare them with validated reference ranges.
Important: An ordinary online color blindness test viewed on an uncalibrated phone or computer should not replace standardized clinical testing.
Occupational standards are also test-specific. For example, since January 1, 2025, the FAA has required approved in-person computerized color vision testing for pilot medical certification, rather than traditional printed screening plates.
10. Comparing the Common Color Vision Tests
Test | Detects | Primary clinical use |
Ishihara | Red-green defects | Quick congenital screening |
HRR | Red-green and blue-yellow defects | Screening, classification, approximate severity |
Farnsworth D-15 | Major hue confusion patterns | Characterizing clinically significant defects |
Lanthony D-15 | Subtle hue discrimination abnormalities | Acquired color vision dysfunction |
FM 100-Hue | Detailed hue discrimination | Quantification and monitoring |
Red desaturation | Interocular perception differences | Bedside optic nerve assessment |
Anomaloscope | Red-green matching abnormalities | Specialized congenital classification |
Computerized tests | Test-dependent cone or color thresholds | Quantitative and occupational evaluation |
11. Congenital vs. Acquired Color Vision Deficiency
One of the most important responsibilities of the optometrist is determining whether a color vision deficiency is longstanding or represents a new clinical finding.
Characteristic | Congenital | Acquired |
Onset | Usually present from childhood | May develop later |
Laterality | Generally bilateral and similar | May be unilateral or asymmetric |
Progression | Usually stable | May change over time |
Common defect | Red-green | Red-green, blue-yellow, or mixed |
Visual acuity | Usually normal in common inherited red-green deficiencies | May be reduced |
Associated disease | Often none | Retinal, optic nerve, neurological, or systemic disease |
Causes of acquired color vision deficiency
Optic nerve disorders: Optic neuritis, compressive optic neuropathy, and other optic neuropathies.
Retinal disorders: Macular degeneration, diabetic retinal disease, and inherited retinal degeneration.
Glaucoma: Can affect chromatic discrimination, including short-wavelength pathways.
Lens opacity: Cataracts can alter color perception, particularly blue-yellow discrimination.
Medication toxicity: Certain medications, including ethambutol and potentially retinal-toxic drugs, may affect color discrimination.
Neurological disease: Lesions involving central visual pathways may produce acquired color perception abnormalities.
These patterns are not absolute. For example, acquired optic nerve disease does not always cause exclusively red-green defects, and some acquired retinal disorders produce mixed abnormalities.
12. Clinical Workup for Abnormal Color Vision Findings
When a patient unexpectedly fails color vision testing, the next step depends on whether the finding appears congenital, acquired, or related to the test conditions.
Recommended clinical evaluation
History: Establish onset, duration, progression, family history, medications, ocular disease, and neurological symptoms.
Visual acuity and refraction: Identify reduced acuity or uncorrected refractive error that could interfere with test performance.
Pupil examination: Evaluate for a relative afferent pupillary defect (RAPD).
Color vision retesting: Confirm the abnormality with appropriate lighting, correction, and an additional test that assesses the suspected deficiency.
Dilated fundus examination: Assess the optic nerve, macula, retina, and media clarity.
OCT: Evaluate the retinal nerve fiber layer, ganglion cell complex, and macula as indicated.
Visual fields: Consider HVF 24-2, 30-2, or 10-2 depending on suspected pathology and visual symptoms.
Additional evaluation: Neuroimaging, laboratory testing, and ophthalmology or neuro-ophthalmology referral should be guided by the clinical presentation.
Clinical decision pathway
Abnormal color vision test
Confirm results and assess test conditions
History + acuity + pupils + ocular examination
Longstanding, symmetric
Possible congenital deficiency
Classify with HRR, D-15, or specialty testing when needed
New, progressive, asymmetric
Possible acquired deficiency
OCT, visual fields, disease-directed investigation and referral
Referral red flags: New color vision loss accompanied by acute visual loss, an RAPD, disc edema, visual field defects, pain with eye movements, or neurological abnormalities warrants prompt evaluation. The urgency depends on the suspected condition, with some presentations requiring same-day emergency assessment.
13. Choosing the Right Color Vision Test in Clinical Practice
For a primary care optometry office, the goal is not necessarily to own every color vision test. It is to select tests that provide useful information for the patient's presentation.
Patient presentation | Suggested testing |
Routine childhood screening | Ishihara or HRR |
Suspected inherited red-green deficiency | Ishihara, followed by HRR if classification is needed |
Suspected optic neuropathy | HRR, red desaturation, and supporting optic nerve evaluation |
Suspected subtle acquired defect | HRR, Lanthony D-15, or advanced testing |
Occupational color vision requirement | Specific approved test mandated by the employer or regulator |
Monitoring color discrimination | Standardized quantitative testing, such as FM 100-Hue or validated computerized testing |
Tips for accurate testing
Test conditions matter just as much as the type of test selected.
Use the manufacturer-recommended lighting, avoid faded or damaged color plates, and document whether the patient was tested monocularly or binocularly. Tinted spectacles and colored contact lenses can affect results and should be removed when safe and appropriate for the examination.
For repeat testing, maintain similar illumination, viewing distance, correction, and test protocols.
Controlled lighting is particularly important for color arrangement tests, as changes in spectral illumination may alter performance.
14. Documenting Color Vision Testing in the Patient Record
A simple notation of "color vision normal" may be sufficient for some routine visits, but abnormal findings deserve more specific documentation.
Include the test name and edition, the eye tested, the score, testing conditions, and any abnormal color confusion pattern.
Example: Routine screening
Sample chart entry
Color Vision: Ishihara 14-plate edition, OD 14/14, OS 14/14. Tested monocularly with appropriate correction under standardized illumination. No red-green deficiency detected by screening.
Example: Suspected acquired dyschromatopsia
Sample chart entry
Color Vision: HRR testing demonstrates reduced color discrimination OS compared with OD. Patient reports new color desaturation OS. Findings warrant further evaluation of optic nerve and macular function, including OCT and automated perimetry, with referral urgency based on associated clinical findings.
Conclusion: Color Vision Testing Is More Than Identifying Color Blindness
Color vision testing provides valuable information about retinal function, optic nerve integrity, and the patient's ability to distinguish important visual signals.
For routine red-green screening, Ishihara remains a practical and effective tool. HRR expands the evaluation to include blue-yellow abnormalities, while Farnsworth arrangement tests and advanced computerized systems allow more detailed investigation.
Most importantly, optometrists should recognize when an abnormal result is likely congenital and when it may indicate an acquired ocular or neurological disorder.
A properly administered color vision test can be a useful part of detecting disease, monitoring visual function, and determining when additional evaluation is necessary.
At OPT-ISM Eye Care, comprehensive eye examinations can help evaluate visual function, including color perception, retinal health, and optic nerve function.
Comments